PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.47%
Negative revenue growth while ADI stands at 5.67%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.47%
Negative gross profit growth while ADI is at 26.14%. Joel Greenblatt would examine cost competitiveness or demand decline.
-11.63%
Negative EBIT growth while ADI is at 13.62%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.39%
Negative operating income growth while ADI is at 13.62%. Joel Greenblatt would press for urgent turnaround measures.
-11.53%
Negative net income growth while ADI stands at 21.89%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.81%
Negative EPS growth while ADI is at 21.52%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.56%
Negative diluted EPS growth while ADI is at 21.52%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.11%
Share reduction while ADI is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
4.58%
Dividend growth above 1.5x ADI's 0.04%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
15.36%
OCF growth at 50-75% of ADI's 22.90%. Martin Whitman would question if the firm lags in monetizing sales effectively.
93.75%
FCF growth above 1.5x ADI's 26.28%. David Dodd would verify if the firm’s strategic investments yield superior returns.
40.67%
10Y revenue/share CAGR under 50% of ADI's 88.14%. Michael Burry would suspect a lasting competitive disadvantage.
22.37%
5Y revenue/share CAGR at 75-90% of ADI's 25.85%. Bill Ackman would encourage strategies to match competitor’s pace.
-15.98%
Negative 3Y CAGR while ADI stands at 1.68%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
80.26%
10Y OCF/share CAGR at 50-75% of ADI's 151.23%. Martin Whitman might fear a structural deficiency in operational efficiency.
16.53%
5Y OCF/share CAGR at 75-90% of ADI's 18.74%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
-14.12%
Negative 3Y OCF/share CAGR while ADI stands at 8.76%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
67.62%
Below 50% of ADI's 175.78%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
15.21%
5Y net income/share CAGR at 50-75% of ADI's 27.98%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-42.90%
Negative 3Y CAGR while ADI is 514.99%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
86.70%
Below 50% of ADI's 363.57%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
94.14%
5Y equity/share CAGR at 75-90% of ADI's 123.33%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
28.44%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
299.73%
10Y dividend/share CAGR above 1.5x ADI's 146.24%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
50.84%
5Y dividend/share CAGR at 50-75% of ADI's 69.61%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
18.30%
3Y dividend/share CAGR similar to ADI's 19.79%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-7.68%
Firm’s AR is declining while ADI shows 18.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
5.38%
Inventory growth well above ADI's 1.38%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.53%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.01%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-6.71%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.20%
Our R&D shrinks while ADI invests at 4.48%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
4.21%
SG&A growth well above ADI's 7.78%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.